Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Ethics Subcommittee (ES), 58397-58398 [2012-23192]
Download as PDF
<![CDATA[
58397
Federal Register / Vol. 77, No. 183 / Thursday, September 20, 2012 / Notices
and CNF and these biomarkers of early
effect, considering potential
confounding factors such as smoking,
age, gender, and workplace coexposures, including non-engineered
ultrafine particles.
The proposed project supports the
NIOSH legislatively mandated
industrywide studies program that
conducts epidemiological and exposure
study will be carried out during the
participants’ regular work shift. There is
no cost to respondents or their
employers other than their time. We
estimate that the average burden per
response to be 22 minutes, and that the
total burden to all respondents will be
37 hours (see table below).
assessment research studies to identify
the occupational causes of disease in the
working population and their offspring
and to effectively communicate study
results to workers, scientists, industry,
and the public.
The questionnaire will be
administered one time only, at the
worksite, to 100 workers involved in the
production and use of CNT or CNT. The
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Nanomaterials Workers ...................................................................................
100
1
22/60
37
Total ..........................................................................................................
........................
........................
........................
37
Dated: September 14, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–23194 Filed 9–19–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
October 11, 2012; 9:00 a.m.–12:00 p.m.,
October 12, 2012
Place: Renaissance Washington, DC
Dupont Circle Hotel, City Center Ballroom,
1143 New Hampshire Avenue NW.,
Washington, District of Columbia 20037.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services (HHS); the Director, Centers for
Disease Control and Prevention (CDC); the
Deputy Director, Office of Infectious Diseases
(OID), CDC; and the Director, National Center
for Emerging and Zoonotic Infectious Disease
(NCEZID), CDC, regarding (1) the practice of
infection control; (2) strategies for
surveillance, prevention, and control of
healthcare-associated infections (e.g.,
nosocomial infections) antimicrobial
resistance and related events in settings
where healthcare is provided, including
VerDate Mar<15>2010
16:11 Sep 19, 2012
Jkt 226001
hospitals, ambulatory and long-term care
facilities, and home health agencies; and (3)
periodic updating of existing guidelines,
development of new guidelines, guideline
evaluation; and other policy statements
regarding the prevention of healthcareassociated infections an healthcare-related
conditions.
Matters To Be Discussed: The agenda will
include updates on CDC’s activities for
healthcare associated infections (HAI), an
update on the draft guideline for prevention
of infections among patients in neonatal
intensive care units (NICU), draft guideline
for the prevention of surgical site infections,
draft guidance for facility adjudication of
infection data, and an update from the
HICPAC surveillance working group.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, l600
Clifton Road, NE., Mailstop A–07, Atlanta,
Georgia 30333 Telephone (404) 639–4045.
Email: hicpac@cdc.gov
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: September 12, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–23193 Filed 9–19–12; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Ethics Subcommittee (ES)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–2:30 p.m., EDT,
Thursday, October 11, 2012.
Place: CDC, Thomas R. Harkin Global
Communications Center, Distance Learning
Auditorium, 1600 Clifton Road, NE., Atlanta,
GA 30333. This meeting is also available by
teleconference. Please dial (877) 928–1204
and enter code 4305992.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 60 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment
period. The public comment period is
tentatively scheduled for 2 p.m.–2:10 p.m.
Purpose: The ES will provide counsel to
the ACD, CDC, regarding a broad range of
public health ethics questions and issues
arising from programs, scientists and
practitioners.
Matters To Be Discussed: Agenda items
will include the following topics: Ethical
considerations relating to use of travel
restrictions for the control of communicable
diseases; addition of ethics standards to the
accreditation process for public health
departments; approaches for evaluating the
impact of public health ethics activities;
progress on developing practical tools to
assist state, tribal, local, and territorial health
departments in their efforts to address public
health ethics challenges; and strategies for
E:\FR\FM\20SEN1.SGM
20SEN1
58398
Federal Register / Vol. 77, No. 183 / Thursday, September 20, 2012 / Notices
increasing collaboration between public
health ethics and public health law.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information: For
security reasons, members of the public
interested in attending the meeting should
contact Drue Barrett, Ph.D., Designated
Federal Officer, ACD, CDC—ES, 1600 Clifton
Road NE., M/S D–50, Atlanta, Georgia 30333.
Telephone: (404) 639–4690. Email:
dbarrett@cdc.gov. The deadline for
notification of attendance is October 1, 2012.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: September 12, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–23192 Filed 9–19–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Title IV–E Plan for Foster Care,
Adoption Assistance, and, optional,
Guardianship Assistance Programs.
OMB No.: 0980–0141.
Description: A title IV–E plan is
required by section 471, part IV–E of the
Social Security Act (the Act) for each
public child welfare agency requesting
Federal funding for foster care, adoption
assistance and guardianship assistance
under the Act. Section 479B of the Act
provides for an Indian tribe, tribal
organization or tribal consortium (Tribe)
to operate a title IV–E program in the
same manner as a State with minimal
exceptions. The Tribe must have an
approved title IV–E Plan. The title IV–
E plan provides assurances the
programs will be administered in
conformity with the specific
requirements stipulated in title IV–E.
The plan must include all applicable
State or Tribal statutory, regulatory, or
policy references and citations for each
requirement as well as supporting
documentation. A title IV–E agency may
use the pre-print format prepared by the
Children’s Bureau of the Administration
for Children and Families or a different
format, on the condition that the format
used includes all of the title IV–E plan
requirements of the law.
Respondents: Title IV–E agencies
administering or supervising the
administration of the title IV–E
programs.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Title IV–E Plan .................................................................................................
17
1
16
272
Estimated Total Annual Burden Hours: 272.
Additional Information
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade, SW., Washington, DC
20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. Email address:
infocollection@acf.hhs.gov.
Administration for Children and
Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2012–23120 Filed 9–19–12; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
mstockstill on DSK4VPTVN1PROD with NOTICES
OMB Comment
[CFDA Number 93.631]
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email:
OIRA_SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
Announcement of the Award of a
Single-Source Program Expansion
Supplement Grant to the University of
Boston for the Institute for Community
Inclusion (ICI) in Boston, MA
VerDate Mar<15>2010
16:11 Sep 19, 2012
Jkt 226001
Administration on
Developmental and Intellectual
Disabilities (AIDD), ACF, HHS.
ACTION: Announcing the award a singlesource program expansion supplement
to the University of Massachusetts for
the Institute for Community Inclusion in
Boston, MA, to support the additional
employment grants that will be
awarded.
AGENCY:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The Administration for
Children and Families (ACF),
Administration on Developmental and
Intellectual Disabilities (AIDD)
announces the award of a grant in the
amount of $300,000 to the University of
Massachusetts for the Institute for
Community Inclusion, Boston, MA.
DATES: The project period for the award
is from September 30, 2012 to
September 29, 2013.
FOR FURTHER INFORMATION CONTACT:
Ophelia McLain, Supervisory Program
Specialist, Administration on
Intellectual and Developmental
Disabilities, 370 L’Enfant Promenade
SW., 2nd Floor East, Washington, DC
20447. Telephone: 202–690–7025;
Email: ophelia.mclain@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: In
September 2011, the Administration on
Developmental and Intellectual
Disabilities (AIDD) awarded a grant to
the ICI to serve as the training and
technical assistance (T/TA) provider to
recipients of Partnerships in
Employment Systems Change grants,
also awarded that same year. AIDD has
expanding the Employment efforts by
awarding two additional Partnerships in
Employment Systems Change grants in
SUMMARY:
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 77, Number 183 (Thursday, September 20, 2012)]
[Notices]
[Pages 58397-58398]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-23192]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--Ethics Subcommittee (ES)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 8:30 a.m.-2:30 p.m., EDT, Thursday, October 11,
2012.
Place: CDC, Thomas R. Harkin Global Communications Center,
Distance Learning Auditorium, 1600 Clifton Road, NE., Atlanta, GA
30333. This meeting is also available by teleconference. Please dial
(877) 928-1204 and enter code 4305992.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 60 people. To
accommodate public participation in the meeting, a conference
telephone line will be available. The public is welcome to
participate during the public comment period. The public comment
period is tentatively scheduled for 2 p.m.-2:10 p.m.
Purpose: The ES will provide counsel to the ACD, CDC, regarding
a broad range of public health ethics questions and issues arising
from programs, scientists and practitioners.
Matters To Be Discussed: Agenda items will include the following
topics: Ethical considerations relating to use of travel
restrictions for the control of communicable diseases; addition of
ethics standards to the accreditation process for public health
departments; approaches for evaluating the impact of public health
ethics activities; progress on developing practical tools to assist
state, tribal, local, and territorial health departments in their
efforts to address public health ethics challenges; and strategies
for
[[Page 58398]]
increasing collaboration between public health ethics and public
health law.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: For security reasons,
members of the public interested in attending the meeting should
contact Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC--
ES, 1600 Clifton Road NE., M/S D-50, Atlanta, Georgia 30333.
Telephone: (404) 639-4690. Email: dbarrett@cdc.gov. The deadline for
notification of attendance is October 1, 2012.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: September 12, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-23192 Filed 9-19-12; 8:45 am]
BILLING CODE 4163-18-P
